DRD1 activation improves adult hippocampal neurogenesis and exerts anxiolytic and antidepressant‐like effect via activation of Wnt/beta‐catenin pathways in rat model of Parkinson’s disease. Here, CTNNB1 is linked to Parkinson disease.